Sportverse Discover Clubs, Events, Races
Home All news JOURNAVX named as official acute pain partner of ASICS Los Angeles Marathon

JOURNAVX named as official acute pain partner of ASICS Los Angeles Marathon

JOURNAVX named as official acute pain partner of ASICS Los Angeles Marathon

The McCourt Foundation (TMF) has named non-opioid prescription medication JOURNAVX (suzetrigine) as the Official Acute Pain Partner of the ASICS Los Angeles Marathon and across its broader endurance event portfolio.

The partnership supports TMF’s broader event series leading into the 2027 ASICS Los Angeles Marathon, scheduled for March 7, 2027. The marathon expects to host over 26,000 runners along its 26.2-mile Stadium-to-the-Stars route from Dodger Stadium to Century City, serving as the final leg of the Conquer LA Challenge series.

Developed by Vertex Pharmaceuticals, JOURNAVX is an oral non-opioid prescription medication indicated for the treatment of moderate-to-severe acute pain in adults, including postoperative pain.

The multi-event partnership with LA Marathon organiser TMF debuted at the Santa Monica Classic and extends across TMF’s southern California and Boston calendar, including the Rose Bowl Half Marathon & 5K, the Boston Waterfront 5K, and the flagship ASICS Los Angeles Marathon.

The sponsorship aims to educate the endurance running community on non-opioid options for managing acute pain during training and recovery, as well as encouraging runners to consult healthcare providers regarding appropriate pain management protocols. The collaboration incorporates product information and educational content across pre- and post-race digital communications, alongside on-site brand activations and spectator engagements across event weekends.

Karen O’Connell, Head of Sponsorship at The McCourt Foundation, said “Our mission at The McCourt Foundation is to empower individuals to live healthier lives and build a healthier world. Partnering with JOURNAVX allows us to extend that commitment beyond the finish line by bringing awareness to nonopioid acute pain treatment options. We are thrilled to welcome JOURNAVX as our Official Acute Pain Partner and provide our running community with valuable information on a nonopioid acute pain management option.”

The McCourt Foundation is a 501(c)(3) non-profit organisation based in Boston and Los Angeles that raises funds for neurological disease research and supports over 155 non-profit charity partners through its mass-participation sporting events.

www.lamarathon.com
www.mccourtfoundation.org
www.journavx.com